Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial

被引：360

作者：

Caraceni, Paolo ^{[1
,2
]}

Riggio, Oliviero ^{[3
]}

Angeli, Paolo ^{[4
]}

Alessandria, Carlo ^{[5
]}

Neri, Sergio ^{[6
]}

Foschi, Francesco G. ^{[7
]}

Levantesi, Fabio ^{[8
]}

Airoldi, Aldo ^{[9
]}

Boccia, Sergio ^{[10
]}

Svegliati-Baroni, Gianluca ^{[11
]}

Fagiuoli, Stefano ^{[12
]}

Romanelli, Roberto G. ^{[13
]}

Cozzolongo, Raffaele ^{[14
]}

Di Marco, Vito ^{[15
]}

Sangiovanni, Vincenzo ^{[16
]}

Morisco, Filomena ^{[17
]}

Toniutto, Pierluigi ^{[18
]}

Tortora, Annalisa ^{[19
]}

De Marco, Rosanna ^{[20
]}

Angelico, Mario ^{[21
]}

Cacciola, Irene ^{[22
]}

Elia, Gianfranco ^{[23
]}

Federico, Alessandro ^{[24
]}

Massironi, Sara ^{[25
,26
]}

Guarisco, Riccardo ^{[27
]}

Galioto, Alessandra ^{[28
]}

Ballardini, Giorgio ^{[29
]}

Rendina, Maria ^{[30
]}

Nardelli, Silvia ^{[3
]}

Piano, Salvatore ^{[4
]}

Elia, Chiara ^{[5
]}

Prestianni, Loredana ^{[6
]}

Cappa, Federica Mirici ^{[7
]}

Cesarini, Lucia ^{[9
]}

Simone, Loredana ^{[10
]}

Pasquale, Chiara ^{[3
]}

Cavallin, Marta ^{[4
]}

Andrealli, Alida ^{[5
]}

Fidone, Federica ^{[6
]}

Ruggeri, Matteo ^{[31
]}

Roncadori, Andrea ^{[32
]}

Baldassarre, Maurizio ^{[1
,2
]}

Tufoni, Manuel ^{[1
,2
]}

Zaccherini, Giacomo ^{[1
,2
]}

Bernardi, Mauro ^{[1
,2
]}

机构：

[1] Univ Bologna, Dept Med & Surg Sci, Bologna, Italy

[2] Univ Bologna, Ctr Appl Biomed Res, Bologna, Italy

[3] Sapienza Univ Rome, Dept Clin Med, Rome, Italy

[4] Univ Padua, Dept Med, Unit Internal Med & Hepatol, Padua, Italy

[5] Univ Turin, Div Gastroenterol & Hepatol, Citta Salute & Sci Hosp, Turin, Italy

[6] Univ Catania, Dept Clin & Expt Med, Catania, Italy

[7] Hosp Faenza, Internal Med, Azienda Unita Sanit Locale Romagna, Faenza, Italy

[8] Hosp Bentivoglio, AUSL Bologna, Internal Med, Bologna, Italy

[9] Osped Niguarda Ca Granda, Dept Gastroenterol & Hepatol, Liver Unit, Milan, Italy

[10] Univ Hosp, Gastroenterol Unit, Ferrara, Italy

[11] Polytech Univ Marche, Dept Gastroenterol, Ancona, Italy

[12] Papa Giovanni XXIII Hosp, Gastroenterol & Transplant Hepatol, Bergamo, Italy

[13] Univ Florence, Dept Expt & Clin Med, Florence, Italy

[14] Natl Inst Gastroenterol S De Bellis, Div Gastroenterol, Bari, Italy

[15] Univ Palermo, Biomed Dept Internal & Specialist Med, Unit Gastroenterol & Hepatol, Palermo, Italy

[16] Cotugno Hosp Naples, Azienda Osped Rilievo Nazl Colli, Naples, Italy

[17] Federico II Univ Naples, Dept Clin Med & Surg, Gastroenterol Unit, Naples, Italy

[18] Univ Udine, Dept Med Area, Internal Med, Udine, Italy

[19] Catholic Univ, Gemelli Fdn, Gastroenterol, Rome, Italy

[20] Hosp Cosenza, Gastroenterol Unit, Cosenza, Italy

[21] Tor Vergata Univ, Liver Unit, Rome, Italy

[22] Univ Hosp Messina, Div Clin & Mol Hepatol, Messina, Italy

[23] Univ Hosp Parma, Infect Dis & Hepatol, Parma, Italy

[24] Univ Campania Luigi Vanvitelli, Dept Clin & Expt Internal Med, Naples, Italy

[25] Fdn Ist Ricovero, Gastroenterol & Endoscopy Unit, Milan, Italy

[26] Cura Carattere Sci Ca Granda Osped Maggiore Polic, Milan, Italy

[27] S Sebastiano Gen Hosp, Internal Med, Rome, Italy

[28] Hosp Dolo, Internal Med, Azienda Unita Locale Sociosanit Serenissima, Venice, Italy

[29] Hosp Rimini, AUSL Romagna, Rimini, Italy

[30] Univ Bari, Sect Gastroenterol, Dept Emergency & Organ Transplantat, Bari, Italy

[31] Catholic Univ, Grad Sch Hlth Econ & Management, Rome, Italy

[32] Cineca Interuniv Consortium, Bologna, Italy

来源：

LANCET | 2018年 / 391卷 / 10138期

关键词：

PERIPHERAL ARTERIAL VASODILATION; PLASMA EXPANDERS; NATURAL-HISTORY; LIVER-DISEASE; ASCITES; INFECTIONS; MANAGEMENT; SURVIVAL; IMPROVES; FAILURE;

D O I：

10.1016/S0140-6736(18)30840-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Background Evidence is scarce on the efficacy of long-term human albumin (HA) administration in patients with decompensated cirrhosis. The human Albumin for the treatmeNt of aScites in patients With hEpatic ciRrhosis (ANSWER) study was designed to clarify this issue. Methods We did an investigator-initiated multicentre randomised, parallel, open-label, pragmatic trial in 33 academic and non-academic Italian hospitals. We randomly assigned patients with cirrhosis and uncomplicated ascites who were treated with anti-aldosteronic drugs (>= 200 mg/day) and furosemide (>= 25 mg/day) to receive either standard medical treatment (SMT) or SMT plus HA (40 g twice weekly for 2 weeks, and then 40 g weekly) for up to 18 months. The primary endpoint was 18-month mortality, evaluated as difference of events and analysis of survival time in patients included in the modified intention-to-treat and per-protocol populations. This study is registered with EudraCT, number 2008-000625-19, and ClinicalTrials. gov, number NCT01288794. Findings From April 2, 2011, to May 27, 2015, 440 patients were randomly assigned and 431 were included in the modified intention-to-treat analysis. 38 of 218 patients died in the SMT plus HA group and 46 of 213 in the SMT group. Overall 18-month survival was significantly higher in the SMT plus HA than in the SMT group (Kaplan-Meier estimates 77% vs 66%; p=0.028), resulting in a 38% reduction in the mortality hazard ratio (0.62 [95% CI 0.40-0.95]). 46 (22%) patients in the SMT group and 49 (22%) in the SMT plus HA group had grade 3-4 non-liver related adverse events. Interpretation In this trial, long-term HA administration prolongs overall survival and might act as a disease modifying treatment in patients with decompensated cirrhosis. (C) 2018 Elsevier Ltd. All rights reserved.

引用

页码：2417 / 2429

页数：13

共 50 条

[1] Long-term albumin administration in decompensated cirrhosis
Bostan, Feyzi
Cekin, Ayhan Hilmi
TURKISH JOURNAL OF GASTROENTEROLOGY, 2019, 30 (04): : 385 - 386
[2] Long-term albumin for decompensated cirrhosis
Baker, Holly
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2018, 3 (08): : 533 - 533
[3] Long-term albumin administration improves survival in patients with decompensated cirrhosis: final results of the "ANSWER" study
Caraceni, P.
Riggio, O.
Angeli, P.
Alessandria, C.
Neri, S.
Foschi, F. G.
Levantesi, F.
Airoldi, A.
Boccia, S.
Baroni, G. S.
Fagiuoli, S.
Laffi, G.
Cozzolongo, R.
Di Marco, V.
Sangiovanni, V.
Morisco, F.
Toniutto, P.
Gasbarrini, A.
De Marco, R.
De Leonardis, F.
Cacciola, I.
Elia, G.
Federico, A.
Massironi, S.
Guarisco, R.
Marin, G.
Ballardini, G.
Rendina, M.
Nardelli, S.
Piano, S.
Elia, C.
Prestianni, L.
Neri, E.
Mastroianni, A.
Cesarini, L.
Simone, L.
Marzioni, M.
Magini, G.
Romanelli, R. G.
Zappimbulso, M.
Calvaruso, V.
Parrella, G.
Caporaso, N.
Pugliese, F.
Tortora, A.
Pasquale, C.
Cavallin, M.
Andrealli, A.
Fidone, F.
Lanzi, A.
JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S93 - S93
[4] Long-term albumin administration in outpatients with decompensated cirrhosis and diabetes mellitus: post-hoc analysis of the ANSWER trial database
Iannone, Giulia
Zaccherini, Giacomo
Pompili, Enrico
Tedesco, Greta
De Venuto, Clara
Baldassarre, Maurizio
Riggio, Oliviero
Angeli, Paolo
Alessandria, Carlo
Neri, Sergio
Foschi, Francesco
Levantesi, Fabio
Airoldi, Aldo
Simone, Loredana
Svegiati-Baroni, Gianluca
Fagiuoli, Stefano
Laffi, Giacomo
Cozzolongo, Raffaele
Di Marco, Vito
Sangiovanni, Vincenzo
Morisco, Filomena
Toniutto, Pierluigi
Tortora, Annalisa
De Marco, Rosanna
Nardelli, Silvia
Piano, Salvatore
Elia, Chiara
Caraceni, Paolo
Bernardi, Mauro
JOURNAL OF HEPATOLOGY, 2024, 80 : S215 - S216
[5] Long-term albumin in cirrhosis: is it the ANSWER?
Garcia-Tsao, Guadalupe
LANCET, 2018, 391 (10138): : 2391 - 2392
[6] LONG-TERM ALBUMIN ADMINISTRATION INCREASES EFFECTIVE ALBUMIN LEVELS IN PATIENTS WITH DECOMPENSATED CIRRHOSIS
Horrillo, Raquel
Mestre, Anna
Vidal, Jordi
Perez, Alba
Torres, Mireia
Paez, Antonio
Arroyo, Vicente
Fernandez, Javier
Claria, Joan
Willis, Todd
Costa, Montserrat
HEPATOLOGY, 2021, 74 : 1241A - 1242A
[7] Long-term albumin administration improves survival in out-patients with decompensated cirrhosis and diabetes: post-hoc analysis of the ANSWER Trial
Zaccherini, G.
De Venuto, C.
Baldassarre, M.
Pompili, E.
Iannone, G.
Riggio, O.
Angeli, P.
Alessandria, C.
Neri, S.
Foschi, F. G.
Levantesi, F.
Airoldi, A.
Simone, L.
Svegliati-Baroni, G.
Fagiuoli, S.
Laffi, G.
Cozzolongo, R.
Di Marco, V.
Sangiovanni, V.
Morisco, F.
Toniutto, P.
Tortora, A.
De Marco, R.
Nardelli, S.
Piano, S.
Elia, C.
Caraceni, P.
Bernardi, M.
DIGESTIVE AND LIVER DISEASE, 2024, 56 : S65 - S66
[8] Long-term albumin administration in patients with decompensated cirrhosis. It is time for a reappraisal
Banares, Rafael
Bernardi, Mauro
LIVER INTERNATIONAL, 2019, 39 (01) : 45 - 48
[9] Long-term albumin improves the outcomes of patients with decompensated cirrhosis and diabetes mellitus: Post hoc analysis of the ANSWER trial
Pompili, Enrico
Baldassarre, Maurizio
Iannone, Giulia
Tedesco, Greta
Nardelli, Silvia
Piano, Salvatore
Alessandria, Carlo
Neri, Sergio
Foschi, Francesco G.
Levantesi, Fabio
Caraceni, Paolo
Bernardi, Mauro
Zaccherini, Giacomo
LIVER INTERNATIONAL, 2024, 44 (09) : 2108 - 2113
[10] Long-term 20% albumin administration normalizes the plasma albumin binding capacity in patients with decompensated cirrhosis
Horrillo, Raquel
Mestre, Anna
Maria Ortiz, Ana
Perez, Alba
Raventos, Aida
Torres, Mireia
Paez, Antonio
Arroyo, Vicente
Fernandez, Javier
Claria, Joan
Willis, Todd
Costa, Montserrat
JOURNAL OF HEPATOLOGY, 2020, 73 : S756 - S756

← 1 2 3 4 5 →